Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Schultz

Showing results (181-190 of 187) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 187 results.
Biology of Reproduction|October 16, 2004
Identification of differentially expressed genes in individual bovine preimplantation embryos produced by nuclear transfer: improper reprogramming of genes required for developmentMartha Pfister-Genskow, Cena Myers, Lynette A Childs, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
1,7-annulated indolocarbazoles as cyclin-dependent kinase inhibitorsRima S Al-awar, James E Ray, Kyle A Hecker, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
Aminoimidazo[1,2-a]pyridines as a new structural class of cyclin-dependent kinase inhibitors. Part 1: Design, synthesis, and biological evaluationCarlos Jaramillo, J Eugenio de Diego, Chafiq Hamdouchi, et al.
Bioorganic & Medicinal Chemistry Letters|October 14, 2003
Aryl[a]pyrrolo[3,4-c]carbazoles as selective cyclin D1-CDK4 inhibitorsConcha Sanchez-Martinez, Chuan Shih, Margaret M Faul, et al.
Journal of Medicinal Chemistry|April 2, 2005
Design of potent and selective 2-aminobenzimidazole-based p38alpha MAP kinase inhibitors with excellent in vivo efficacyAlfonso de Dios, Chuan Shih, Beatriz López de Uralde, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazolesThomas A Engler, Kelly Furness, Sushant Malhotra, et al.
Molecular Cancer Therapeutics|January 30, 2004
The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo[1,2-a]pyridinesChafiq Hamdouchi, Heather Keyser, Elizabeth Collins, et al.
Pageof 19

Showing results (181-190 of 187) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 187 results.
Biology of Reproduction|October 16, 2004
Identification of differentially expressed genes in individual bovine preimplantation embryos produced by nuclear transfer: improper reprogramming of genes required for developmentMartha Pfister-Genskow, Cena Myers, Lynette A Childs, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
1,7-annulated indolocarbazoles as cyclin-dependent kinase inhibitorsRima S Al-awar, James E Ray, Kyle A Hecker, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
Aminoimidazo[1,2-a]pyridines as a new structural class of cyclin-dependent kinase inhibitors. Part 1: Design, synthesis, and biological evaluationCarlos Jaramillo, J Eugenio de Diego, Chafiq Hamdouchi, et al.
Bioorganic & Medicinal Chemistry Letters|October 14, 2003
Aryl[a]pyrrolo[3,4-c]carbazoles as selective cyclin D1-CDK4 inhibitorsConcha Sanchez-Martinez, Chuan Shih, Margaret M Faul, et al.
Journal of Medicinal Chemistry|April 2, 2005
Design of potent and selective 2-aminobenzimidazole-based p38alpha MAP kinase inhibitors with excellent in vivo efficacyAlfonso de Dios, Chuan Shih, Beatriz López de Uralde, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazolesThomas A Engler, Kelly Furness, Sushant Malhotra, et al.
Molecular Cancer Therapeutics|January 30, 2004
The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo[1,2-a]pyridinesChafiq Hamdouchi, Heather Keyser, Elizabeth Collins, et al.
Pageof 19